Invention Grant
- Patent Title: Use of adenovirus and nucleic acids coding therefor
-
Application No.: US16176461Application Date: 2018-10-31
-
Publication No.: US10731136B2Publication Date: 2020-08-04
- Inventor: Per Sonne Holm
- Applicant: Per Sonne Holm
- Agency: Casimir Jones, S.C.
- Agent Peter J. Schlueter
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@37af3cd0 com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@2724bfba com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@6c961804 com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@648da79f
- Main IPC: A61K35/761
- IPC: A61K35/761 ; C12N7/00 ; C07K14/005 ; C12N15/86 ; A61K35/763 ; A61K48/00 ; A61K38/00
Abstract:
The invention relates to the use of a virus, preferably an adenovirus, for producing a medicament. Said virus is replication-deficient in cells which do not contain YB-1 in the core and codes for an oncogene or ongogene product, especially an oncogene protein, which transactivates at least one viral gene, preferably an adenoviral gene, said gene being selected among the group comprising E1B55kDa, E4orf6, E4orf3, and E3ADP.
Public/Granted literature
- US20190055522A1 USE OF ADENOVIRUS AND NUCLEIC ACIDS CODING THEREFOR Public/Granted day:2019-02-21
Information query
